Package-Ref? Liver Cancer PLAC8/BMPR1A for Methylation control
CBPE0221
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| Introduction | ||||||
| Description | DNA methylation is an epigenetic modification, a form of chemical modification of DNA, which refers to the carbon 5 of cytosine in the genomic CpG dinucleotide under the action of DNA methyltransferase. covalently bonded to a methyl group. It can change genetic expression without changing the DNA sequence. This package contains multiple detection samples for Liver cancer, We use simulated clinical cell lines to prepare them. If you are testing PLAC8/BMPR1A, you can choose this product. |
|||||
| Technical Data | ||||||
| Classification | Cat No. | Name | Description | Region | Methylation level | |
| 質(zhì)控品 | CBPE0221-1 | 肝癌-PLAC8,BMPR1A陽(yáng)性甲基化 | PLAC8 Methylation Positive control | chr4:84035895-84035987 (hg19) | 94.20% | |
| BMPR1A Methylation Positive control | chr10:88683965-88684051 (hg19) | 95.75% | ||||
| CBPE0221-2 | 肝癌-PLAC8,BMPR1A陰性甲基化 | PLAC8 Methylation Negative control | chr4:84035895-84035987 (hg19) | N/A | ||
| BMPR1A Methylation Negative control | chr10:88683965-88684051 (hg19) | N/A | ||||
| CBPE0221-3 | 肝癌-PLAC8陰性甲基化，BMPR1A陽(yáng)性甲基化 | PLAC8 Methylation Negative control | chr4:84035895-84035987 (hg19) | 0.00% | ||
| BMPR1A Methylation Positive control | chr10:88683965-88684051 (hg19) | 96.59% | ||||
| CBPE0221-4 | 肝癌-BMPR1A陰性甲基化，PLAC8陽(yáng)性甲基化 | PLAC8 Methylation Positive control | chr4:84035895-84035987 (hg19) | N/A | ||
| BMPR1A Methylation Negative control | chr10:88683965-88684051 (hg19) | N/A | ||||
| Classification | Cat No. | Name | Description | Region | Methylation level | |
| 單陽(yáng)PLAC8-參考品 | 單陽(yáng)PLAC8區(qū)段-強(qiáng)陽(yáng)性參考品-1 | CBPE0221-5 | PLAC8強(qiáng)陽(yáng)性甲基化參考品，BMPR1A陰性甲基化 | PLAC8 Methylation Reference Standard with 90.00% | chr4:84035895-84035987 (hg19) | N/A |
| BMPR1A Methylation Negative control | chr10:88683965-88684051 (hg19) | N/A | ||||
| 單陽(yáng)PLAC8區(qū)段-強(qiáng)陽(yáng)性參考品-2 | CBPE0221-6 | PLAC8強(qiáng)陽(yáng)性甲基化參考品，BMPR1A陰性甲基化 | PLAC8 Methylation Reference Standard with 10.00% | chr4:84035895-84035987 (hg19) | N/A | |
| BMPR1A Methylation Negative Reference Standard | chr10:88683965-88684051 (hg19) | N/A | ||||
| 單陽(yáng)PLAC8區(qū)段-弱陽(yáng)性參考品 | CBPE0221-7 | PLAC8弱陽(yáng)性甲基化參考品，BMPR1A陰性甲基化 | PLAC8 Methylation Reference Standard with 3.00% | chr4:84035895-84035987 (hg19) | N/A | |
| BMPR1A Methylation Negative Reference Standard | chr10:88683965-88684051 (hg19) | N/A | ||||
| 單陽(yáng)PLAC8區(qū)段-檢測(cè)限參考品 | CBPE0221-8 | PLAC8檢測(cè)限甲基化參考品，BMPR1A陰性甲基化 | PLAC8 Methylation Reference Standard with 1.00% | chr4:84035895-84035987 (hg19) | N/A | |
| BMPR1A Methylation Negative Reference Standard | chr10:88683965-88684051 (hg19) | N/A | ||||
| 單陽(yáng)PLAC8區(qū)段-陰性參考品 | CBPE0221-9 | 肝癌-PLAC8,BMPR1A陰性甲基化 | PLAC8 Methylation Negative control | chr4:84035895-84035987 (hg19) | N/A | |
| BMPR1A Methylation Negative control | chr10:88683965-88684051 (hg19) | N/A | ||||
| 單陽(yáng)PLAC8區(qū)段-精密度參考品 | CBPE0221-10 | PLAC8弱陽(yáng)性甲基化參考品，BMPR1A陰性甲基化 | PLAC8 Methylation Reference Standard with 3.00% | chr4:84035895-84035987 (hg19) | N/A | |
| BMPR1A Methylation Negative Reference Standard | chr10:88683965-88684051 (hg19) | N/A | ||||
| CBPE0221-11 | 肝癌-PLAC8,BMPR1A陰性甲基化 | PLAC8 Methylation Negative control | chr4:84035895-84035987 (hg19) | N/A | ||
| BMPR1A Methylation Negative control | chr10:88683965-88684051 (hg19) | N/A | ||||
| Classification | Cat No. | Name | Description | Region | Methylation level | |
| 單陽(yáng)BMPR1A-參考品 | 單陽(yáng)BMPR1A區(qū)段-強(qiáng)陽(yáng)性參考品-1 | CBPE0221-12 | BMPR1A強(qiáng)陽(yáng)性甲基化參考品，PLAC8陰性甲基化 | BMPR1A Methylation Reference Standard with 90.00% | chr10:88683965-88684051 (hg19) | 96.59% |
| PLAC8 Methylation Negative control | chr4:84035895-84035987 (hg19) | 0.00% | ||||
| 單陽(yáng)BMPR1A區(qū)段-強(qiáng)陽(yáng)性參考品-2 | CBPE0221-13 | BMPR1A強(qiáng)陽(yáng)性甲基化參考品，PLAC8陰性甲基化 | BMPR1A Methylation Reference Standard with 10.00% | chr10:88683965-88684051 (hg19) | N/A | |
| PLAC8 Methylation Negative control | chr4:84035895-84035987 (hg19) | N/A | ||||
| 單陽(yáng)BMPR1A區(qū)段-弱陽(yáng)性參考品 | CBPE0221-14 | BMPR1A弱陽(yáng)性甲基化參考品，PLAC8陰性甲基化 | BMPR1A Methylation Reference Standard with 3.00% | chr10:88683965-88684051 (hg19) | N/A | |
| PLAC8 Methylation Negative control | chr4:84035895-84035987 (hg19) | N/A | ||||
| 單陽(yáng)BMPR1A區(qū)段-檢測(cè)限參考品 | CBPE0221-15 | BMPR1A檢測(cè)限甲基化參考品，PLAC8陰性甲基化 | BMPR1A Methylation Reference Standard with 1.00% | chr10:88683965-88684051 (hg19) | N/A | |
| PLAC8 Methylation Negative control | chr4:84035895-84035987 (hg19) | N/A | ||||
| 單陽(yáng)BMPR1A區(qū)段-陰性參考品 | CBPE0221-16 | 肝癌-PLAC8,BMPR1A陰性甲基化 | PLAC8 Methylation Negative control | chr4:84035895-84035987 (hg19) | N/A | |
| BMPR1A Methylation Negative control | chr10:88683965-88684051 (hg19) | N/A | ||||
| 單陽(yáng)BMPR1A區(qū)段-精密度參考品 | CBPE0221-17 | BMPR1A弱陽(yáng)性甲基化參考品，PLAC8陰性甲基化 | BMPR1A Methylation Reference Standard with 3.00% | chr10:88683965-88684051 (hg19) | N/A | |
| PLAC8 Methylation Negative control | chr4:84035895-84035987 (hg19) | N/A | ||||
| CBPE0221-18 | 肝癌-PLAC8,BMPR1A陰性甲基化 | PLAC8 Methylation Negative control | chr4:84035895-84035987 (hg19) | N/A | ||
| BMPR1A Methylation Negative control | chr10:88683965-88684051 (hg19) | N/A | ||||
| 備注 | 1. 質(zhì)控品也叫準(zhǔn)確度標(biāo)準(zhǔn)品，用于定性判斷； 2. 參考品用于定性和定量的判斷，其中強(qiáng)陽(yáng)、弱陽(yáng)、檢測(cè)限、精密度、特異性的判定需要視具體項(xiàng)目而定，本產(chǎn)品的判定僅為內(nèi)部標(biāo)準(zhǔn)； 3. 質(zhì)控品用于性能評(píng)價(jià)，出廠檢，試劑盒日常檢測(cè)判定，參考品用于性能評(píng)價(jià)，出廠檢； 4.上述產(chǎn)品只展示了部分結(jié)果，甲基化程度可以定制。 |
|||||
| Product Information | ||||||
| Intended Use | Research Use Only | |||||
| Concentration | Download for COA | |||||
| Purity | Download for COA | |||||
| DNA electrophoresis | Download for COA | |||||
| Format | Genomic DNA | |||||
| Unit Size | 1ug | |||||
| Storage | 2-8°C | |||||
| Expiry | 36 months from the date of manufacture | |||||
| Remark | The data in the instruction manual is the data of a single test, and the specific data of each batch is subject to delivery. | |||||
